Last update 07 Sep 2026

Maxacalcitol/Betamethasone butyrate propionate

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Betamethasone butyrate propionate/maxacalcitol, M 8010, M 801801
+ [4]
Target
GR x VDR
Action
agonists
Mechanism
GR agonists(Glucocorticoid receptor agonists), VDR agonists(Vitamin D receptor agonists)
Therapeutic Areas
Immune System DiseasesSkin and Musculoskeletal Diseases
Active Indication
Psoriasis vulgarisPsoriasis
Inactive Indication-
Originator Organization
Chugai Pharmaceutical Co., Ltd.Chugai Pharmaceutical Co., Ltd.
Active Organization
Maruho Co., Ltd.Maruho Co., Ltd.Chugai Pharmaceutical Co., Ltd.Chugai Pharmaceutical Co., Ltd.
Inactive Organization-
License Organization
Maruho Co., Ltd.Maruho Co., Ltd.Chugai Pharmaceutical Co., Ltd.Chugai Pharmaceutical Co., Ltd.
Drug Highest PhaseApproved
First Approval Date
Japan (28 Mar 2016),
Psoriasis
Regulation-
Login to view timeline

Structure/Sequence

Molecular FormulaC26H42O4
InChIKeyDTXXSJZBSTYZKE-ZDQKKZTESA-N
CAS Registry103909-75-7
View All Structures (2)

Related

100 Clinical Results associated with Maxacalcitol/Betamethasone butyrate propionate
Login to view more data
100 Translational Medicine associated with Maxacalcitol/Betamethasone butyrate propionate
Login to view more data
100 Patents (Medical) associated with Maxacalcitol/Betamethasone butyrate propionate
Login to view more data
100 Deals associated with Maxacalcitol/Betamethasone butyrate propionate
Login to view more data

External Link

KEGGWikiATCDrug Bank
D10788-
D05
-

R&D Status

10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Psoriasis vulgaris
Japan
Maruho Co., Ltd.Maruho Co., Ltd.
22 Nov 2016
Psoriasis
Japan
Chugai Pharmaceutical Co., Ltd.Chugai Pharmaceutical Co., Ltd.
28 Mar 2016
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Hiro LS Researcher
The AI Search Engine Built to Accelerate Biopharma Decisions
Search across billion-scale life sciences data to uncover signals, validate evidence, and act with confidence.
Ask any biopharma research question→
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, Patsnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Discover Synapse Data Servers
Synapse data is now integrated into the PatSnap LS Model Context Protocol (MCP) service. Customize your LLM agent now using our MCP server!
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free